Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.43 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.41 |
| ▸ | FEN1 | P39748 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27879614 | 0.82 | ATM (0.68) | PTGS2ATMCYP1A2PDK2ALOX5AP | |
| SCHEMBL9862848 | 0.82 | CYP1A2 (0.63) | PTGS2PTGS1CYP1A2MAP4K4MEN1 | |
| SCHEMBL4694014 | 0.80 | ATM (0.56) | CNR1CNR2ATMCYP1A2CYP19A1 | |
| SCHEMBL31491188 | 0.79 | CYP1A2 (0.60) | PTGS2PTGS1CYP1A2MAP4K4MEN1 | |
| SCHEMBL18045052 | 0.79 | CYP1A2 (0.68) | PTGS2PTGS1CYP1A2PDK2MAP4K4 | |
| SCHEMBL11151194 | 0.79 | CYP1A2 (0.60) | PTGS2PTGS1CYP1A2MAP4K4MEN1 | |
| SCHEMBL28209270 | 0.79 | ATM (0.46) | PTGS2ATMPDK2NPC1RAB9A | |
| SCHEMBL27764876 | 0.79 | ATM (0.46) | CNR1CNR2ATMCYP1A2PDK2 | |
| SCHEMBL2009521 | 0.78 | CYP2A6 (0.56) | CNR1CNR2ATMCYP1A2PDK2 | |
| SCHEMBL29926517 | 0.77 | CYP1A2 (0.74) | PTGS2PTGS1CYP1A2MAP4K4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170373257-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-12-28 | — | — | US | disclosed |
| US-20170373257-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170373257-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | B4GALT1, CCNT1, CYP1A1 | CNR1 1006/4885CNR2 1278/4885PTGS2 1712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.